TY - JOUR
T1 - The relationship between heavy menstrual bleeding, iron deficiency, and iron deficiency anemia
AU - Munro, Malcolm G.
AU - Mast, Alan E.
AU - Powers, Jacquelyn M.
AU - Kouides, Peter A.
AU - O'Brien, Sarah H.
AU - Richards, Toby
AU - Lavin, Michelle
AU - Levy, Barbara S.
N1 - Funding Information:
M.G.M. reports serving as a consultant for the following entities: AbbVie Inc; American Regent, Inc; Daiichi Sankyo, Ltd; Hologic, Inc; KARL STORZ Endoscopy-America, Inc; Myovant Sciences; Pharmacosmos A/S; and Vifor. M.G.M. also reports receiving indirect research funding from AbbVie Inc and Pharmacosmos A/S. A.E.M. reports receiving research funding from Novo Nordisk and Pharmacosmos A/S and has received honoraria for serving on advisory boards for Novo Nordisk and Vega Therapeutics and for educational seminars from Novo Nordisk. J.M.P. reports previously serving as a consultant for Pharmacosmos LLC. P.A.K. reports serving as a consult on the Data Safety Monitoring Board for Uniqure and Tremeau Pharmaceuticals. S.H.O. reports serving as a steering committee member for Bristol Myers Squibb and Pfizer. T.R. reports serving as a consultant for Pharmacosmos, Vifor, Pfizer, and BIoAge Labs, receiving grant funding from the Western Australian Medical Research Future Fund (MRFF), the Australian MRFF and HM Revenue and Customs, the United Kingdom National Institute for Health and Care Research’s Health Technology Assessment Programme and Efficiency and Mechanism Evaluation Programme, and receiving grant and nonfinancial support from Pharmacosmos A/S and Vifor. M.L. reports serving as a constant for Sobi Pharmaceuticals and CSL Behring and receiving indirect educational funding from Takeda. B.S.L. reports serving as a consultant for Myovant Sciences, Channel Medsystems, and Hologic and previously serving as a consultant for AbbVie, Inc.
Publisher Copyright:
© 2023 Elsevier Inc.
PY - 2023/7
Y1 - 2023/7
N2 - For reproductive-aged women, the symptom of heavy menstrual bleeding is highly prevalent and a major contributor to iron deficiency and its most severe manifestation, iron deficiency anemia. It is recognized that these 2 clinical entities are not only highly prevalent, but their interrelationship is poorly appreciated and frequently normalized by society, healthcare providers, and affected girls and women themselves. Both heavy menstrual bleeding and iron deficiency, with or without anemia, adversely impact quality of life—heavy menstrual bleeding during the episodes of bleeding and iron deficiency on a daily basis. These combined issues adversely affect the lives of reproductive-aged girls and women of all ages, from menarche to menopause, and their often-insidious nature frequently leads to normalization. The effects on cognitive function and the related work and school absenteeism and presenteeism can undermine the efforts and function of women in all walks of life, be they students, educators, employers, or employees. There is also an increasing body of evidence that suggests that iron deficiency, even in early pregnancy, may adversely impact fetal neurodevelopment with enduring effects on a spectrum of cognitive and psychological disorders, critically important evidence that begs the normalization of iron stores in reproductive-aged women. The authors seek to raise individual, societal, and professional awareness of this underappreciated situation in a fashion that leads to meaningful and evidence-based changes in clinical guidance and healthcare policy directed at preventing, screening, diagnosing, and appropriately managing both disorders. This manuscript provides evidence supporting the need for action and describes the elements necessary to address this pervasive set of conditions that not only affect reproductive-aged girls and women but also the lives of children everywhere.
AB - For reproductive-aged women, the symptom of heavy menstrual bleeding is highly prevalent and a major contributor to iron deficiency and its most severe manifestation, iron deficiency anemia. It is recognized that these 2 clinical entities are not only highly prevalent, but their interrelationship is poorly appreciated and frequently normalized by society, healthcare providers, and affected girls and women themselves. Both heavy menstrual bleeding and iron deficiency, with or without anemia, adversely impact quality of life—heavy menstrual bleeding during the episodes of bleeding and iron deficiency on a daily basis. These combined issues adversely affect the lives of reproductive-aged girls and women of all ages, from menarche to menopause, and their often-insidious nature frequently leads to normalization. The effects on cognitive function and the related work and school absenteeism and presenteeism can undermine the efforts and function of women in all walks of life, be they students, educators, employers, or employees. There is also an increasing body of evidence that suggests that iron deficiency, even in early pregnancy, may adversely impact fetal neurodevelopment with enduring effects on a spectrum of cognitive and psychological disorders, critically important evidence that begs the normalization of iron stores in reproductive-aged women. The authors seek to raise individual, societal, and professional awareness of this underappreciated situation in a fashion that leads to meaningful and evidence-based changes in clinical guidance and healthcare policy directed at preventing, screening, diagnosing, and appropriately managing both disorders. This manuscript provides evidence supporting the need for action and describes the elements necessary to address this pervasive set of conditions that not only affect reproductive-aged girls and women but also the lives of children everywhere.
KW - abnormal uterine bleeding
KW - heavy menstrual bleeding
KW - iron deficiency
KW - iron deficiency anemia
UR - https://www.scopus.com/pages/publications/85150413222
U2 - 10.1016/j.ajog.2023.01.017
DO - 10.1016/j.ajog.2023.01.017
M3 - Review article
C2 - 36706856
AN - SCOPUS:85150413222
SN - 0002-9378
VL - 229
SP - 1
EP - 9
JO - American Journal of Obstetrics and Gynecology
JF - American Journal of Obstetrics and Gynecology
IS - 1
ER -